SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis
Open accessAbstract
Background: Solute carrier family 7 member 11(SLC7A11) is a component of cysteine/glutamate transporter, which plays a key role in tumor growth; however, its underlying effect on radiosensitivity in esophageal squamous cell carcinoma (ESCC) remains unclear. This study aimed to clarify SLC7A11’s expression and correlation with nuclear expression of nuclear factor erythroid-2 ( NRF2)-associated radioresistance in ESCC. Methods: We included 127 ESCC patients who received radical chemoradiotherapy. Immunohistochemical staining was used to detect SLC7A11 and NRF2 nuclear expression, and the relationship between clinicopathological characteristics and survival rates or therapy response were evaluated. Western blot, dual-reporter assays and Chromatin immunoprecipitation (ChIP)-sequencing were used to analyze their relationship in vitro. Their roles in radioresistance were then investigated through multiple validation steps. Results: NRF2 nuclear expression and SLC7A11 expression were overexpressed in ESCC tissues and were positively correlated with one another. NRF2 nuclear expression was significantly associated with tumor length, lymph node metastasis, and TNM stage, while SLC7A11 expression was associated with lymph node metastasis. Patients with high NRF2 nuclear expression and SLC7A11 expression had significantly shorter overall and progression-free survival, and poor treatment response. The multivariate model showed that NRF2 nuclear expression and SLC7A11 expression, sex and tumor location are independent prognostic factors. In vitro analysis confirmed that hyperactivation of NRF2 induced SLC7A11 expression by directly binding to its promoter region, promoting radioresistance, reducing radiotherapy-induced lipid peroxidation levels, PTGS2 expression, and radiotherapy-related ferroptosis morphologic features. Conclusion: Our study reveals a connection between high SLC7A11 expression and NRF2 nuclear expression in patients with ESCC that was related to worse survival and poorer therapy outcomes. SLC7A11-mediated ferroptosis inhibition induced NRF2-associated radioresistance, highlighting potential of NRF2/SLC7A11/ferroptosis axis as future therapeutic targets against therapy resistance biomarker.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
All ApoE isoforms increased the expression of known NRF2 target genes including SLC7A11, AKR1C1, and FTH1.
“and increased the expression of known target genes of this transcription factor including SLC7A11, AKR1C1, and FTH1 (fig. S5S) (41–45).”
From Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis (2024) · cites this paper as [43]
The Results section reports that NRF2 directly binds the SLC7A11 promoter and induces its expression in esophageal squamous cell carcinoma cells. The cited paper therefore supports identifying SLC7A11 as an NRF2 target, but our copy does not establish AKR1C1 or FTH1 as NRF2 targets. It also does not report an effect of ApoE isoforms; the citing sentence points to its own figure for that result. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · see citing works
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695 · see citing works
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727 · see citing works
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy
Koppula, P., Zhuang, L., & Gan, B. (2020) · Protein & Cell · doi:10.1007/s13238-020-00789-5 · Cited by 2,551 · see citing works
NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
Dodson, M., Castro-Portuguez, R., & Zhang, D. D. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101107 · Cited by 2,435 · see citing works
Reactive Oxygen Species-Induced Lipid Peroxidation in Apoptosis, Autophagy, and Ferroptosis
Su, L.-J., Zhang, J.-H., Gomez, H., Murugan, R., Hong, X., Xu, D., Jiang, F., & Peng, Z.-Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5080843 · Cited by 2,166 · see citing works
Self-citationSun, X., Ou, Z., Chen, R., Niu, X., Chen, D., Kang, R., & Tang, D. (2016) · Hepatology · doi:10.1002/hep.28251 · Cited by 2,012 · see citing works
JASPAR 2020: update of the open-access database of transcription factor binding profiles
Fornes, O., Castro-Mondragon, J. A., Khan, A., van der Lee, R., Zhang, X., Richmond, P. A., Modi, B. P., Correard, S., Gheorghe, M., Baranašić, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1001 · Cited by 1,763 · see citing works
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672 · see citing works
The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
Lei, G., Zhang, Y., Koppula, P., Liu, X., Zhang, J., Lin, S. H., Ajani, J. A., Xiao, Q., Liao, Z., Wang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-019-0263-3 · Cited by 1,318 · see citing works
Self-citationCysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294 · see citing works
Lagergren, J., Smyth, E. C., Cunningham, D., & Lagergren, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31462-9 · Cited by 1,152 · see citing works
Lang, X., Green, M. D., Wang, W., Yu, J., Choi, J. E., Jiang, L., Liao, P., Zhou, J., Zhang, Q., Dow, A., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0338 · Cited by 1,066 · see citing works
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Zhang, Y., Shi, J., Liu, X., Li, F., Gong, Z., Koppula, P., Sirohi, K., Li, X., Wei, Y., Lee, H., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0178-0 · Cited by 1,024 · see citing works
Park, E., & Chung, S. W. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2064-5 · Cited by 897 · see citing works
The Roles of NRF2 in Modulating Cellular Iron Homeostasis
Kerins, M. J., & Ooi, A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7176 · Cited by 741 · see citing works
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728 · see citing works
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer
Sui, X., Zhang, R., Liu, S., Duan, T., Zhai, L., Zhang, M., Han, X., Xiang, Y., Huang, X., Lin, H., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01371 · Cited by 703 · see citing works
Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis
Fan, Z., Wirth, A.-K., Chen, D., Wruck, C. J., Rauh, M., Buchfelder, M., & Savaskan, N. E. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.65 · Cited by 695 · see citing works
Roh, J.-L., Kim, E. H., Jang, H., & Shin, D. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.010 · Cited by 662 · see citing works
Purhonen, J., Banerjee, R., McDonald, A. E., Fellman, V., & Kallijärvi, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa516 · Cited by 657 · see citing works
Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer
Shin, D., Kim, E. H., Lee, J., & Roh, J. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.426 · Cited by 536 · see citing works
Ferroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 519 · see citing works
Clockophagy is a novel selective autophagy process favoring ferroptosis
Yang, M., Chen, P., Liu, J., Zhu, S., Kroemer, G., Klionsky, D. J., Lotze, M. T., Zeh, H. J., Kang, R., & Tang, D. (2019) · Science Advances · doi:10.1126/sciadv.aaw2238 · Cited by 491 · see citing works
Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis
Lee, Y., Lee, D.-H., Choudry, H. A., Bartlett, D. L., & Lee, Y. J. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0055 · Cited by 434 · see citing works
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer
Yang, J., Zhou, Y., Xie, S., Wang, J., Li, Z., Chen, L., Mao, M., Chen, C., Huang, A., Chen, Y., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02012-7 · Cited by 386 · see citing works
Jeong, Y., Hoang, N. T., Lovejoy, A. F., Stehr, H., Newman, A. M., Gentles, A. J., Kong, W. W., Truong, D., Martin, S. A., Chaudhuri, A. A., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0127 · Cited by 348 · see citing works
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Chen, D., Tavana, O., Chu, B., Erber, L. N., Chen, Y., Baer, R. J., & Gu, W. J. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.009 · Cited by 321 · see citing works
Cui, Y., Chen, H., Xi, R., Cui, H., Zhao, Y., Xu, E., Yan, T., Lu, X., Huang, F., Kong, P., et al. (2020) · Cell Research · doi:10.1038/s41422-020-0333-6 · Cited by 274 · see citing works
Role of Nrf2 and Its Activators in Respiratory Diseases
Liu, Q., Gao, Y., & Ci, X. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7090534 · Cited by 273 · see citing works
SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin, W., Wang, C., Liu, G., Bi, C., Wang, X., Zhou, Q., & Jin, H. (2020) · PubMed Central · Cited by 266 · see citing works
A Convergence-Based Framework for Cancer Drug Resistance
Konieczkowski, D. J., Johannessen, C. M., & Garraway, L. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.025 · Cited by 258 · see citing works
Satoh, H., Moriguchi, T., Takai, J., Ebina, M., & Yamamoto, M. P. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4499 · Cited by 251 · see citing works
Shibata, T., Kokubu, A., Saito, S., Narisawa-Saito, M., Sasaki, H., Aoyagi, K., Yoshimatsu, Y., Tachimori, Y., Kushima, R., Kiyono, T., et al. (2011) · Neoplasia · doi:10.1593/neo.11750 · Cited by 224 · see citing works
Nrf2 and STAT3 Alleviates Ferroptosis-Mediated IIR-ALI by Regulating SLC7A11
Qiang, Z., Dong, H., Xia, Y., Chai, D., Hu, R., & Jiang, H. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5146982 · Cited by 210 · see citing works
Okuno, S., Sato, H., Kuriyama-Matsumura, K., Tamba, M., Wang, H., Sohda, S., Hamada, H., Yoshikawa, H., Kondo, T., & Bannai, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600786 · Cited by 191 · see citing works
Emerging role of NRF2 in ROS-mediated tumor chemoresistance
Xue, D., Zhou, X., & Qiu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110676 · Cited by 188 · see citing works
Takahashi, N., Cho, P., Selfors, L. M., Kuiken, H. J., Kaul, R., Fujiwara, T., Harris, I. S., Zhang, T., Gygi, S. P., & Brugge, J. S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.010 · Cited by 186 · see citing works
Gai, C., Yu, M., Li, Z., Wang, Y., Ding, D., Zheng, J., Lv, S., Zhang, W., & Li, W. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29221 · Cited by 149 · see citing works
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia
Rosa, P. L., Petrillo, S., Turchi, R., Berardinelli, F., Schirinzi, T., Vasco, G., Lettieri‐Barbato, D., Fiorenza, M. T., Bertini, E., Aquilano, K., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101791 · Cited by 149 · see citing works
Tao, S., de la Vega, M. R., Chapman, E., Ooi, A., & Zhang, D. D. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22745 · Cited by 136 · see citing works
Nrf2 is a potential therapeutic target in radioresistance in human cancer
Zhou, S., Ye, W., Shao, Q., Zhang, M., & Liang, J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.09.001 · Cited by 115 · see citing works
Lien, E. C., Ghisolfi, L., Geck, R. C., Asara, J. M., & Toker, A. (2017) · Science Signaling · doi:10.1126/scisignal.aao6604 · Cited by 105 · see citing works
Increased xCT Expression Correlates With Tumor Invasion and Outcome in Patients With Glioblastomas
Takeuchi, S., Wada, K., Toyooka, T., Shinomiya, N., Shimazaki, H., Nakanishi, K., Nagatani, K., Otani, N., Osada, H., Uozumi, Y., et al. (2012) · Neurosurgery · doi:10.1227/neu.0b013e318276b2de · Cited by 102 · see citing works
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Li, B., Yang, L., Peng, X., Fan, Q., Wei, S., Yang, S., Li, X., Jin, H., Wu, B., Huang, M., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110710 · Cited by 101 · see citing works
Self-citationBAP1 inhibits the ER stress gene regulatory network and modulates metabolic stress response
Dai, F., Lee, H., Zhang, Y., Zhuang, L., Yao, H., Xi, Y., Xiao, Z.-D., You, M. J., Li, W., Su, X., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1619588114 · Cited by 94 · see citing works
Nagane, M., Kanai, E., Shibata, Y., Shimizu, T., Yoshioka, C., Maruo, T., & Yamashita, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195151 · Cited by 85 · see citing works
Effects of Selenium Nanoparticles Combined With Radiotherapy on Lung Cancer Cells
Tian, J., Wei, X., Zhang, W., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.598997 · Cited by 81 · see citing works
Zhang, L., Huang, Y., Ling, J., Zhuo, W., Yu, Z., Luo, Y., & Zhu, Y. (2018) · Future Oncology · doi:10.2217/fon-2017-0540 · Cited by 75 · see citing works
xCT inhibition sensitizes tumors to γ-radiation via glutathione reduction
Cobler, L., Zhang, H., Suri, P., Park, C., & Timmerman, L. (2018) · Oncotarget · doi:10.18632/oncotarget.25794 · Cited by 72 · see citing works
Kawasaki, Y., Okumura, H., Uchikado, Y., Kita, Y., Sasaki, K., Owaki, T., Ishigami, S., & Natsugoe, S. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3600-2 · Cited by 69 · see citing works
Xia, D., Zhang, X., Ma, Y., Zhao, Z., Zhao, R., & Wang, Y. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00456-6 · Cited by 62 · see citing works
Zhao, Q., Mao, A., YAN, J., Sun, C., Di, C., Zhou, X. H., Li, H., Guo, R., & Zhang, H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3301 · Cited by 61 · see citing works
Zhao, X., Gao, M., Liang, J., Chen, Y., Wang, Y., Wang, Y., Xiao, Y., Zhao, Z., Wan, X., Jiang, M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639851 · Cited by 60 · see citing works
Transcriptional regulation of human Oct4 by steroidogenic factor‐1
Yang, H., Do, H., Kim, D., Park, J., Chang, W.-K., Chung, H., Choi, S.-Y., & Kim, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21244 · Cited by 53 · see citing works
Shiozaki, A., Iitaka, D., Ichikawa, D., Nakashima, S., Fujiwara, H., Okamoto, K. K., Kubota, T., Komatsu, S., Kosuga, T., Takeshita, H., et al. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0847-5 · Cited by 52 · see citing works
Ferino, A., Rapozzi, V., & Xodo, L. E. (2019) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2019.111672 · Cited by 51 · see citing works
Ma, Z., Zhang, H., Lian, M., Yue, C., Dong, G., Jin, Y., Li, R., Wan, H., Wang, R., Wang, Y., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5976 · Cited by 48 · see citing works
Self-citationZhang, G., Wang, W., Yao, C., Ren, J., Zhang, S., & Han, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.04.095 · Cited by 45 · see citing works
Extracellular redox state shift: A novel approach to target prostate cancer invasion
Zhong, W., Weiss, H. L., Jayswal, R. D., Hensley, P. J., Downes, L. M., Clair, D. K. S., & Chaiswing, L. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.023 · Cited by 40 · see citing works
Alterations in System xc− Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2
Carpi-Santos, R., & Calaza, K. D. C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0961-8 · Cited by 37 · see citing works
Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways
Lee, Y., Kim, W. I., Bae, J. H., Cho, M. K., Lee, S.-H., Nam, H. S., Choi, I. H., & Cho, S. W. (2020) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2020.98.4.159 · Cited by 36 · see citing works
Silva‐Adaya, D., Ramos-Chávez, L. A., Petrosyan, P., González-Alfonso, W. L., Pérez-Acosta, A., & Gonsebatt, M. E. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00017 · Cited by 29 · see citing works
SETD2 epidermal deficiency promotes cutaneous wound healing via activation of AKT/mTOR Signalling
Li, X., Liu, C., Zhu, Y., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13045 · Cited by 23 · see citing works
Self-citationOno, K., Furugen, A., Kurosawa, Y., Jinno, N., Narumi, K., Kobayashi, M., & Iseki, K. (2018) · Placenta · doi:10.1016/j.placenta.2018.11.010 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2020. https://doi.org/10.1007/s13238-020-00789-5. · DOI
Cited by
Sorted by citations
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
Jyotsana, N., Ta, K. T. L., & DelGiorno, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.858462 · Cited by 275 · see citing works
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282 · see citing works
Targeting ferroptosis in acute kidney injury
Ni, L., Cheng, Y., & Wu, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04628-9 · Cited by 225 · see citing works
SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
Lee, J., & Roh, J. (2022) · Antioxidants · doi:10.3390/antiox11122444 · Cited by 206 · see citing works
Ferroptosis as a potential target for cancer therapy
Chen, Z., Wang, W., Razak, S. R. A., Han, T., Ahmad, N. H., & Li, X. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05930-w · Cited by 208 · see citing works
An, L., Li, M., & Jia, Q. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01839-2 · Cited by 178 · see citing works
Metabolic heterogeneity in cancer
Demicco, M., Liu, X., Leithner, K., & Fendt, S. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00963-z · Cited by 183 · see citing works
Li, Y., Yang, W., Zheng, Y., Dai, W., Ji, J., Wu, L., Cheng, Z., Zhang, J., Li, J., Xu, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02567-z · Cited by 169 · see citing works
Self-citationNrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Li, L., Wu, Q., Lu, F., Lei, J., Zhou, Y., Liu, Y., Zhu, N., You, Y., Ning, Z., She, T., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1184079 · Cited by 132 · see citing works
Liu, R., Bian, Y., Liu, L., Liu, L., Liu, X., & Ma, S. (2022) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2022.5121 · Cited by 112 · see citing works
Radiotherapy modulates tumor cell fate decisions: a review
Chen, H., Han, Z., Luo, Q., Wang, Y., Li, Q., Zhou, L., & Zuo, H.-D. (2022) · Radiation Oncology · doi:10.1186/s13014-022-02171-7 · Cited by 95 · see citing works
Jiang, K., Yin, X., Zhang, Q., Yin, J., Tang, Q., Xu, M., Wu, L., Shen, Y., Zhou, Z., Yu, H., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102626 · Cited by 90 · see citing works
Self-citationXing, N., Du, Q., Guo, S., Xiang, G., Zhang, Y., Meng, X., Li, X., & Wang, S. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01407-z · Cited by 88 · see citing works
The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy
Jiang, X., Yu, M., Wang, W.-K., Zhu, L., Wang, X., Jin, H.-C., & Feng, L. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01336-2 · Cited by 88 · see citing works
Self-citationThe Role of SLC7A11 in Cancer: Friend or Foe?
Li, S., Lu, Z., Sun, R., Guo, S., Gao, F., Cao, B., & Aa, J. (2022) · Cancers · doi:10.3390/cancers14133059 · Cited by 85 · see citing works
Zhu, X., & Li, S. (2023) · Advanced Science · doi:10.1002/advs.202300824 · Cited by 84 · see citing works
Targeting SIRT3 sensitizes glioblastoma to ferroptosis by promoting mitophagy and inhibiting SLC7A11
Li, X., Zhang, W., Xing, Z., Hu, S., Zhang, G., Wang, T., Wang, T., Fan, Q., Chen, G., Cheng, J., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06558-0 · Cited by 80 · see citing works
Deregulated transcription factors in cancer cell metabolisms and reprogramming
Kant, R., Manne, R., Anas, M., Penugurti, V., Chen, T., Pan, B., Hsu, C.-C., & Lin, H. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.001 · Cited by 72 · see citing works
Bao, L., Zhao, C., Feng, L., Zhao, Y., Duan, S., Qiu, M., Wu, K., Zhang, N., Hu, X., & Fu, Y. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112909 · Cited by 71 · see citing works
Self-citationButyrate dictates ferroptosis sensitivity through FFAR2-mTOR signaling
Wang, G., Qin, S., Chen, L., Geng, H., Zheng, Y., Xia, C., Yao, J., & Deng, L. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05778-0 · Cited by 70 · see citing works
He, J., Wang, X., Chen, K., Zhang, M., & Wang, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115241 · Cited by 69 · see citing works
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Gu, X., Mu, C., Zheng, R., Zhang, Z., Zhang, Q., & Liang, T. (2024) · Antioxidants · doi:10.3390/antiox13070778 · Cited by 75 · see citing works
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Zeng, W., Long, X., Liu, P., & Xie, X. (2023) · International Journal of Cancer · doi:10.1002/ijc.34486 · Cited by 69 · see citing works
Hushmandi, K., Einollahi, B., Saadat, S. H., Lee, E. H. C., Farani, M. R., Okina, E., Huh, Y. S., Nabavi, N., Salimimoghadam, S., & Kumar, A. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101952 · Cited by 61 · see citing works
Luo, H., Wang, X., Song, S., Wang, Y., Dan, Q., & Ge, H. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2101769 · Cited by 67 · see citing works
El‐Mahdy, H. A., Elsakka, E. G. E., El-Husseiny, A. A., Ismail, A., Yehia, A. M., Abdelmaksoud, N. M., Elshimy, R. A. A., Noshy, M., & Doghish, A. S. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154316 · Cited by 66 · see citing works
Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis
He, Y., Xi, J., Fang, J., Zhang, B., & Cai, W. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.025 · Cited by 66 · see citing works
Protein modification and degradation in ferroptosis
Wang, Y., Ding, Y., Liu, J., Tang, D., & Chen, X. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103259 · Cited by 62 · see citing works
Ferroptosis and its role in skeletal muscle diseases
Wang, Y., Zhang, Z., Jiao, W., Wang, Y., Wang, X., Zhao, Y., Fan, X., Tian, L., Li, X., & Mi, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1051866 · Cited by 57 · see citing works
Wang, Y., Wang, Y., Pan, J., Gan, L., & Xue, J. (2023) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2023.109689 · Cited by 53 · see citing works
RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy
Shi, J.-X., Zhang, Z., Yin, H.-Z., Piao, X.-J., Liu, C., Liu, Q.-J., Zhang, J.-C., Zhou, W.-X., Liu, F., Yang, F., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02132-6 · Cited by 54 · see citing works
Self-citationRegulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis
Su, Z., Liu, Y., Wang, L., & Gu, W. J. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101254 · Cited by 56 · see citing works
Nrf2‐Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute‐on‐Chronic Liver Failure
Wu, J., Xue, R., Wu, M., Yin, X., Xie, B., & Meng, Q. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4505513 · Cited by 50 · see citing works
Self-citationAmos, A., Jiang, N., Zong, D., Gu, J., Zhou, J., Li, Y., He, X., Xu, Y., & Wu, L. (2023) · BMC Cancer · doi:10.1186/s12885-022-10465-y · Cited by 48 · see citing works
Yu, X., Wang, Y., Tan, J., Li, Y., Yang, P., Liu, X., Lai, J., Zhang, Y., Cai, L., Gu, Y., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01800-2 · Cited by 48 · see citing works
Artemisinin inhibits neuronal ferroptosis in Alzheimer’s disease models by targeting KEAP1
Deng, P.-X., Silva, M., Yang, N., Wang, Q., Meng, X., Ye, K., Gao, H., & Zheng, W. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01378-6 · Cited by 51 · see citing works
Ferroptosis in gastrointestinal cancer: from mechanisms to implications
Zhang, R., Kang, R., & Tang, D. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216147 · Cited by 46 · see citing works
Cao, J., Zhou, T., Wu, T., Lin, R., Huang, J. W., Shi, D., Yu, J., Ren, Y., Qian, C., He, L., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07354-0 · Cited by 48 · see citing works
Cooperation effects of radiation and ferroptosis on tumor suppression and radiation injury
Su, J., Bian, C., Zheng, Z., Wang, H., Meng, L., Xin, Y., & Jiang, X. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.951116 · Cited by 46 · see citing works
The KEAP1-NRF2 System and Esophageal Cancer
Hirose, W., Oshikiri, H., Taguchi, K., & Yamamoto, M. P. (2022) · Cancers · doi:10.3390/cancers14194702 · Cited by 46 · see citing works
Cao, Y. J., Zhang, H., Tang, J., et al. (2022) · Disease Markers · doi:10.1155/2022/4607966 · Cited by 45 · see citing works
Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy
Yu, S., Xiao, H., Ma, L., Zhang, J., & Zhang, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188946 · Cited by 48 · see citing works
Self-citationDisulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications
Gu, Q., An, Y., Xu, M., Huang, X., Chen, X., Li, X., Shan, H., & Zhang, M. (2024) · Aging and Disease · doi:10.14336/ad.2024.0083 · Cited by 45 · see citing works
Chen, L., Ning, J., Linghu, L., Tang, J. M., Liu, N., Long, Y., Sun, J., Lv, C., Shi, Y., Tao, T., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2410619 · Cited by 43 · see citing works
Tan, X., Huang, X., Niu, B., Guo, X., Lei, X., & Qu, B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1102158 · Cited by 40 · see citing works
ARE-PROTACs Enable Co-degradation of an Nrf2–MafG Heterodimer
Ji, J., Ma, S., Zhu, Y., Zhao, J., Tong, Y., You, Q., & Jiang, Z. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01909 · Cited by 45 · see citing works
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
Occhiuto, C. J., Moerland, J. A., Leal, A. S., Gallo, K. A., & Liby, K. T. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.2191 · Cited by 40 · see citing works
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
Zhuo, S., He, G., Chen, T., Li, X., Liang, Y., Wu, W., Weng, L., Feng, J., Gao, Z., & Yang, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.974156 · Cited by 43 · see citing works
Contribution of Lipid Oxidation and Ferroptosis to Radiotherapy Efficacy
Pearson, A. N., Carmicheal, J., Jiang, L., Lei, Y. L., & Green, M. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212603 · Cited by 38 · see citing works
He, X., Zhou, Y., Chen, W., Zhao, X., Duan, L., Zhou, H., Li, M., Yin, Y., Zhao, J., Guo, Y., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02636-3 · Cited by 38 · see citing works
Mohan, M., Mannan, A., Kakkar, C., & Singh, T. G. (2024) · Current Drug Targets · doi:10.2174/0113894501320839240918110656 · Cited by 37 · see citing works
Li, X., Xu, H., Zhao, X., Li, Y., Lv, S., Zhou, W. J., Wang, J., Sun, Z., Li, Y., & Guo, C. (2024) · Particle and Fibre Toxicology · doi:10.1186/s12989-024-00579-5 · Cited by 36 · see citing works
Sun, M., Chen, J., Liu, F., et al. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00444 · Cited by 36 · see citing works
NFE2L2 and ferroptosis resistance in cancer therapy
Tang, D., & Kang, R. (2024) · Cancer Drug Resistance · doi:10.20517/cdr.2024.123 · Cited by 39 · see citing works
Pan, C., Chen, G., Zhao, X., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175317 · Cited by 36 · see citing works
Wang, H., Fan, S., Zhan, Y., Peng, S., & Wang, W. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127976 · Cited by 35 · see citing works
Counteraction of Myocardial Ferritin Heavy Chain Deficiency by Heme Oxygenase-1
Machado, S. E., Spangler, D., Stacks, D. A., Darley-Usmar, V. M., Benavides, G. A., Xie, M., Balla, J., & Zarjou, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158300 · Cited by 33 · see citing works
Zhu, X., Huang, N., Ji, Y., Sheng, X., Huo, J., Zhu, Y., Huang, M., He, W., & Ma, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115567 · Cited by 33 · see citing works
Xi, Y., Shen, Y., Chen, L., Tan, L., Shen, W., & Niu, X. (2023) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2023.08.010 · Cited by 31 · see citing works
Rai, A., Patwardhan, R. S., Jayakumar, S., Pachpatil, P. K., Das, D., Panigrahi, G. C., Gota, V., Patwardhan, S., & Sandur, S. K. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01233-8 · Cited by 32 · see citing works
Xia, W., Zhu, Z., Xiang, S., & Yang, Y. (2023) · Journal of Ginseng Research · doi:10.1016/j.jgr.2023.06.006 · Cited by 32 · see citing works
Yan, L., Hu, H., Feng, L., Li, Z., Chunyan, Z., Zhang, J., Yin, X., & Li, B. (2024) · Medical Oncology · doi:10.1007/s12032-024-02483-6 · Cited by 31 · see citing works
Self-citationHuang, C., & Zhan, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.851540 · Cited by 29 · see citing works
The role of ferroptosis in esophageal cancer
Wang, Z., Wu, S., Zhu, C., & Shen, J. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02685-w · Cited by 31 · see citing works
Gong, G., Ganesan, K., Liu, Y., Huang, Y., Luo, Y., Wang, X., Zhang, Z., & Zheng, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117655 · Cited by 28 · see citing works
Emerging trends of phytochemicals as ferroptosis modulators in cancer therapy
Khan, F., Pandey, P., Verma, M., Ramniwas, S., Lee, D., Moon, S., Park, M. N., Upadhyay, T. K., & Kim, B. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116363 · Cited by 28 · see citing works
Kalarikkal, S. P., Kumar, M. N., Rajendran, S., Bethi, C. M. S., Ravilla, J., Janakiraman, N., & Sundaram, G. M. (2025) · iScience · doi:10.1016/j.isci.2025.112556 · Cited by 29 · see citing works
Ferroptosis-related signaling pathways in cancer drug resistance
Yang, Y., Yu, S., Liu, W., Zhuo, Y., Qu, C., & Zeng, Y. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.151 · Cited by 28 · see citing works
Li, O., An, K., Wang, H., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70270 · Cited by 27 · see citing works
Comprehensive Analysis of YTHDF1 Immune Infiltrates and ceRNA in Human Esophageal Carcinoma
Liu, X., Kui, X.-Y., Gao, Y. P., Chen, X., Zeng, J., Liu, X., Zhang, Y., Zhang, Y., & Pei, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.835265 · Cited by 27 · see citing works
Ferrostatin-1 inhibits fibroblast fibrosis in keloid by inhibiting ferroptosis
Yang, L., Li, X., & Wang, Y. (2024) · PeerJ · doi:10.7717/peerj.17551 · Cited by 26 · see citing works
Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
Chen, X., Zhang, L., He, Y., Huang, S., Chen, S., Zhao, W., & Yu, D. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01645-1 · Cited by 26 · see citing works
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis
More, S., Bonnereau, J., Wouters, D., Spotbeen, X., Karras, P., Rizzollo, F., Killian, T., Venken, T., Naulaerts, S., Vervoort, E., et al. (2024) · Science Advances · doi:10.1126/sciadv.adp6164 · Cited by 25 · see citing works
Mechanism of metal ion-induced cell death in gastrointestinal cancer
Luan, M., Feng, Z., Zhu, W., Xing, Y., Ma, X., Zhu, J., Wang, Y., & Jia, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116574 · Cited by 25 · see citing works
Important molecular mechanisms in ferroptosis
Lai, L., Tan, M., Hu, M., Yue, X., Tao, L., Zhai, Y., & Li, Y. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05009-w · Cited by 24 · see citing works
Recent advances of ferroptosis in tumor: From biological function to clinical application.
Hu, S., Chu, Y., Zhou, X., & Wang, X. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.115419 · Cited by 29 · see citing works
Magnolol against enterovirus 71 by targeting Nrf2-SLC7A11-GSH pathway
Zhao, D., Guo, X., Lin, B., Huang, R., Li, H., Wang, Q., Zeng, Y., Shang, Y., & Wu, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116866 · Cited by 23 · see citing works
Du, F., Wang, G., Dai, Q., Huang, J. H., Li, J., Liu, C., Du, K., Tian, H., Deng, Q., Xie, L., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00748-4 · Cited by 22 · see citing works
Self-citationSahu, M., & Jain, U. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167764 · Cited by 22 · see citing works
Samec, M., Mazuráková, A., Lučanský, V., Koklesová, L., Péčová, R., Péč, M. J., Golubnitschaja, O., AL-Ishaq, R. K., Čaprnda, M., Gašpar, Ľ., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175655 · Cited by 22 · see citing works
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance
D’Aprile, S., Denaro, S., Pavone, A. M., Giallongo, S., Giallongo, C., Distefano, A., Salvatorelli, L., Torrisi, F., Giuffrida, R., Forte, S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04664-9 · Cited by 23 · see citing works
Gong, G., Wan, Y., Liu, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111959 · Cited by 22 · see citing works
Wang, T., Liang, S., Li, Y., Wang, X., Wang, H., Guo, J., & Li, M. (2023) · PeerJ · doi:10.7717/peerj.15216 · Cited by 21 · see citing works
AhR signaling modulates Ferroptosis by regulating SLC7A11 expression
Kou, Z., Tran, F., Colon, T. M., Shteynfeld, Y., Noh, S., Chen, F., Choi, B. H., & Dai, W. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116936 · Cited by 21 · see citing works
Hushmandi, K., Klionsky, D. J., Aref, A. R., Bonyadi, M., Reiter, R. J., Nabavi, N., Salimimoghadam, S., & Saadat, S. H. (2024) · Non-coding RNA Research · doi:10.1016/j.ncrna.2024.05.008 · Cited by 21 · see citing works
Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer
Wang, P., Long, F., Lin, H., Wang, S., & Wang, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7848811 · Cited by 21 · see citing works
NRF2 Antagonizes HIV-1 Tat and Methamphetamine-Induced BV2 Cell Ferroptosis by Regulating SLC7A11
Lin, S., Cheng, H., Yang, G., Wang, C., Leung, C., Zhang, S., Tan, Y., Zhang, H., Wang, H., Miao, L., et al. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00645-4 · Cited by 20 · see citing works
Pan, R., Wang, R., Cheng, F., Wang, L., Cui, Z., She, J., & Yang, X. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01208-8 · Cited by 20 · see citing works
Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets
Orang, F. N., & Shadbad, M. A. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06732-4 · Cited by 22 · see citing works
Leng, L., Li, P., Liu, R., Francis, O. B., Song, S., Sui, Y., Yang, Y., Wang, Y., Sun, X., Miao, R., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119630 · Cited by 21 · see citing works
Zhu, X., Chen, X., Qiu, L., Zhu, J., & Wang, J. (2022) · Oncology Letters · doi:10.3892/ol.2022.13479 · Cited by 19 · see citing works
RetractedGlutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets
Zhong, X., He, Z., Li, Y., Fan, Y., Yu, T., Kang, Y., & Bi, Q. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20656 · Cited by 20 · see citing works
Han, F., Chen, S., Zhang, K., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05057-2 · Cited by 19 · see citing works
Zhang, L., Luo, D., Ren, H., Fan, W., Yu, Z., Wang, S., Wu, X., Xu, Y., & Li, S. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156912 · Cited by 18 · see citing works
Wang, Z., Bi, Y., Li, K., Song, Z., Pan, C., Zhang, S., Lan, X., Foulkes, N. S., & Zhao, H. (2023) · Environmental Science Nano · doi:10.1039/d2en00757f · Cited by 18 · see citing works
Yang, J., Liu, J., Kuang, W., Lin, Y., Zhong, S., Kraithong, S., Zhang, X., Wong, I. N., & Huang, R. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130703 · Cited by 18 · see citing works
Ferroptosis and cancer: when iron turns against tumors
Toyokuni, S., Kong, Y., Maeda, Y. K., Lyu, Q., Ohara, Y., Sato, K., Motooka, Y., Nakamura, K., & Tanaka, H. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05982-5 · Cited by 20 · see citing works
Zhu, J., Zhao, Y., Wu, G., Zhang, X., Chen, Q., Yang, B., Guo, X., Ji, S., & Gu, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7465880 · Cited by 17 · see citing works
Ferroptosis and its emerging role in esophageal cancer
Maimaitizunong, R., Wang, K., & Li, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1027912 · Cited by 17 · see citing works
Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis
Savic, D., Steinbichler, T. B., Ingruber, J., Negro, G., Aschenbrenner, B., Riechelmann, H., Ganswindt, U., Skvortsov, S., Dudás, J., & Skvortsova, I. (2023) · Cells · doi:10.3390/cells12020336 · Cited by 17 · see citing works
- Authors
- Feng, L., Zhao, K., Sun, L., Yin, X., Zhang, J., Liu, C., & Li, B.
- Affiliations
- Shandong Tumor Hospital (CN)
- Binzhou Medical University (CN)
- Corresponding author
- Li, Baosheng
- Venue
- Journal of Translational Medicine
- Published
- 2021-08-26
- Volume
- 19
- Issue
- 1
- Pages
- 367-367
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC8393811
- OpenAlex
- W3194902068
- Semantic Scholar
- e55a74d417d2810a7e103ad2eaccdd036e12dc8c
- Cited by
- 277
- References
- 65
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 67 · 2023: 61 · 2022: 35 · 2021: 1
- FWCI
- 26.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (No. 81874224)
- Academic promotion program of Shandong First Medical University (2019LJ004)
- National Key Research and Development Program of China (2016YFC0105106)
- Taishan Scholar Construction Project (ts20120505)
- Tumor prevention and control Joint Fund of Shandong province natural science fund (ZR2019LZL008)
- Yantai Science and Technology Innovation Development Program (2020YT06121070)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- SLC7A11, Nrf2, esophageal squamous cell carcinoma, radioresistance (biology), ferroptosis, chemoradiotherapy, prognostic factors, lipid peroxidation, cyclooxygenase-2, promoter binding, treatment resistance
- MeSH terms
- Esophageal Squamous Cell Carcinoma, Ferroptosis, Esophageal Neoplasms, Head and Neck Neoplasms, Humans, Prognosis, Radiation Tolerance, Amino Acid Transport System y+, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review